Silver Book

Silver Book Fact

Mitral regurgitation patients who did not undergo surgery saw an increased use of medical therapies from 12% to 47% over 4.5 years.

Goel S, Bajaj N, Agaarwall B, et al. Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure. J Am Coll Cardiol. 2014; 63(2). http://www.onlinejacc.org/content/63/2/185

Reference

Title
Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure
Publication
J Am Coll Cardiol
Publication Date
2014
Authors
Goel S, Bajaj N, Agaarwall B, et al
Volume & Issue
Volume 63, Issue 2
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Publications

Silver Book: Valve Disease Volume

 https://www.silverbook.org/wp-content/uploads/2018/02/SB-Vol-TN.jpg Thumbnail

Connected Facts

Aortic Stenosis

Fact image
Aortic stenosis often undertreated
Cost of Disease

Mitral Valve Disease

Fact image
Human Burden

Mitral Valve Disease

Fact image
Patients with severe MR who don’t have surgery have mortality rates of 20% after 1-year and 50% after 5-years
Human Burden

Aortic Stenosis

Fact image
Medicare patients with sSAS have an average lifespan of 1.8 years without repair or replacement
Human Burden

Related Facts

  • In 2009, the estimated direct and indirect cost of cardiovascular disease is $165.4 billion.  
  • The total direct and indirect cost of CVD and stroke in the United States for 2008 is estimated at $448.5 billion. This figure includes health expenditures (direct costs, which include…  
  • Around 7.9 million Americans have had a myocardial infarction.  
  • Incidence of venous thromboembolism increases with age
    Incidence of venous thromboembolism increases significantly with age—from less than 5 cases per 100,000 people ages 15 and younger, to around 500 cases per 100,000 people ages 80 and older.  
  • Of those who have a first myocardial infarction, 16% of men and 22% of women ages 40-69 have a recurrent myocardial infarction or fatal coronary heart disease within 5 years.